Back to VRTX
STATE STREET CORP VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
24
Latest value
$5.9B
Q2 2026
Peak value
$5.9B
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $9.9M |
| Q4 2023 | $4.9B |
| Q1 2024 | $12.1M |
| Q1 2024 | $5B |
| Q2 2024 | $36M |
| Q2 2024 | $5.5B |
| Q3 2024 | $52.4M |
| Q3 2024 | $5.5B |
| Q4 2024 | $73.3M |
| Q4 2024 | $4.8B |
| Q1 2025 | $48.9M |
| Q1 2025 | $5.7B |
| Q2 2025 | $55.3M |
| Q2 2025 | $5.2B |
| Q3 2025 | $42.5M |
| Q3 2025 | $4.5B |
| Q4 2025 | $36.9M |
| Q4 2025 | $5.3B |
| Q1 2026 | $22.7M |
| Q1 2026 | $5.2B |
| Q2 2026 | $23.6M |
| Q2 2026 | $5.9B |
| Q2 2026 | $23.6M |
| Q2 2026 | $5.9B |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $5.9B | 11.87M | — | — |
| Q2 2026 | $23.6M | 2.06M | — | — |
| Q2 2026 | $5.9B | 11.87M | — | — |
| Q2 2026 | $23.6M | 2.06M | — | — |
| Q1 2026 | $5.2B | 11.73M | — | — |
| Q1 2026 | $22.7M | 1.91M | — | — |
| Q4 2025 | $5.3B | 11.69M | — | — |
| Q4 2025 | $36.9M | 1.85M | — | — |
| Q3 2025 | $4.5B | 11.61M | — | — |
| Q3 2025 | $42.5M | 1.71M | — | — |
| Q2 2025 | $5.2B | 11.78M | — | — |
| Q2 2025 | $55.3M | 1.57M | — | — |
| Q1 2025 | $5.7B | 11.79M | — | — |
| Q1 2025 | $48.9M | 1.40M | — | — |
| Q4 2024 | $4.8B | 11.98M | — | — |
| Q4 2024 | $73.3M | 1.37M | — | — |
| Q3 2024 | $5.5B | 11.82M | — | — |
| Q3 2024 | $52.4M | 1.36M | — | — |
| Q2 2024 | $5.5B | 11.73M | — | — |
| Q2 2024 | $36M | 998.3K | — | — |
| Q1 2024 | $5B | 12.01M | — | — |
| Q1 2024 | $12.1M | 380.7K | — | — |
| Q4 2023 | $4.9B | 12.08M | — | — |
| Q4 2023 | $9.9M | 369.2K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B